Structure, function and stability analysis on potential deleterious mutation ensemble in glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for early detection of LUAD

Life Sci. 2024 Dec 1:358:123127. doi: 10.1016/j.lfs.2024.123127. Epub 2024 Oct 18.

Abstract

Aims: Lung adenocarcinoma (LUAD) is the most prominent histological subtype among the lung cancer which is a leading cause in the cancer mortality rate. High mutational and glycolytic rates are the major reported alterations in the lung cancer. Here in our study we are elucidating the structural and functional role of key glycolytic enzyme Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and associated SNPs in LUAD progression.

Materials and methods: Our gene expression analysis reveals high expression of GAPDH in the LUAD. In silico tools and analysis were used for the identification and characterization of the deleterious SNPs. Molecular Docking and dynamics simulations (MDS) studies characterized the structural consequences of prioritized deleterious mutations.

Key findings: The sequence based analysis to identify SNPs in GAPDH resulted in 28 deleterious SNPs and 6 SNPs among them showed deleterious and damaging effect. The structural based analysis resulted in 2 stabilizing SNPs of rs ids rs11549328 (D39Y) and rs200102749 (S51Y) in the conserved domain. The IDR and PTM analysis of the GAPDH sequence resulted an IDR region from 191 to 194 positions with an IDR score of 0.511, 0.520, 0.517 and 0.503 with the PTM modifications.

Significance: The identified deleterious SNPs (D39Y and S51Y) fall in the functional and conserved domain of GAPDH. In addition, the existence of PTMs within the IDR region of the GAPDH may contribute to its enhanced glycolytic activity in LUAD. The results of our study provide potential background deleterious mutants the pathological aspect of GAPDH in LUAD progression.

Keywords: Deleterious SNP; GAPDH; IDR; Lung adenocarcinoma; Molecular dynamics simulation; PTM.

MeSH terms

  • Adenocarcinoma of Lung* / genetics
  • Adenocarcinoma of Lung* / pathology
  • Early Detection of Cancer / methods
  • Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)
  • Glyceraldehyde-3-Phosphate Dehydrogenases* / genetics
  • Humans
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Mutation*
  • Polymorphism, Single Nucleotide*

Substances

  • Glyceraldehyde-3-Phosphate Dehydrogenases
  • GAPDH protein, human
  • Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)